For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
Protagenic Therapeutics Inc (NASDAQ: PTIX) closed the day trading at $1.62 down -1.82% from the previous closing price of $1.65. In other words, the price has decreased by -$1.82 from its previous closing price. On the day, 0.56 million shares were traded. PTIX stock price reached its highest trading level at $1.65 during the session, while it also had its lowest trading level at $1.46.
Ratios:
For a better understanding of PTIX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.29 and its Current Ratio is at 0.29.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PTIX now has a Market Capitalization of 3123194.
Stock Price History:
The Beta on a monthly basis for PTIX is 1.09, which has changed by -0.77335167 over the last 52 weeks, in comparison to a change of 0.12529528 over the same period for the S&P500. Over the past 52 weeks, PTIX has reached a high of $14.28, while it has fallen to a 52-week low of $1.52. The 50-Day Moving Average of the stock is -36.20%, while the 200-Day Moving Average is calculated to be -52.02%.
Shares Statistics:
Over the past 3-months, PTIX traded about 89.50K shares per day on average, while over the past 10 days, PTIX traded about 109940 shares per day. A total of 1.93M shares are outstanding, with a floating share count of 1.84M. Insiders hold about 4.47% of the company’s shares, while institutions hold 4.30% stake in the company. Shares short for PTIX as of 1756425600 were 89908 with a Short Ratio of 0.64, compared to 1753920000 on 10905. Therefore, it implies a Short% of Shares Outstanding of 89908 and a Short% of Float of 11.219999999999999.
